Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

TriLink – saRNAs

Why use saRNA?

  • Compared to traditional mRNAs, saRNAs offer the advantages of:
    • Achieve higher and more sustained protein expression
    • Low dose requirements
    • High protein expression

This makes TriLink’s saRNAs highly attractive for the development of innovative vaccines and gene therapies.

saRNAs contain alphavirus sequences including non-structural proteins (nsp1-4), allowing them to self-replicate and amplify protein expression.


Video: How is self-amplifying RNA (saRNA) different from messenger RNA (mRNA)?
Higher and more durable protein expression from saRNA compared to mRNA in 293T cells.

Utilise TriLinks CleanCap technology for:

Optimal translation: Capped with CleanCap® AU, which mimics alphavirus 5′ end, to provide an optimal Cap 1 for efficient amplification and expression

And TriLinks CleanScript IVT and CleanScribe RNA polymerase:

Enhanced protein expression: Produced with TriLink’s proprietary CleanScript® IVT and CleanScribe™ RNA Polymerase to improve quality, minimise dsRNA, and increase protein expression

Increased protein expression in 293T cells transfected with saRNAs produced using CleanScript IVT and CleanScribe RNA Polymerase (n = 3, 24 hr post transfection).

Discover the power of TriLink's premade and custom saRNAs

Download Brochure >

Visit the TriLink website

Click Here >


TriLink saRNA Ordering Information

Request a Quote

Request Quote

Recent Posts

TriLink – CleanCap® M6 IVT Kit, High Yield

Streamline your mRNA synthesis with TriLink’s CleanCap® IVT kits, which yield up to 1 mg per 100 µL reaction. Designed for efficiency and excellence, these kits include all…

Read full article

Roche – KAPA EvoPlus V2 and EvoPrep Kits

Roche KAPA kits offer a range of high-performance products for molecular biology applications, particularly in next-generation sequencing (NGS) and PCR. (more…)

Read full article

The 2025-26 Merck Analyte Quarterly Update is Here!

Beyond Biomarkers!  Expect reliable measurements, a simplified user experience, and knowledgeable scientific partners to help drive your biomarker projects. Abacus dx is committed to delivering…

Read full article